
NeuroMetrix NURO
Annual report 2024
added 03-31-2025
NeuroMetrix P/E Ratio 2011-2026 | NURO
Annual P/E Ratio NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.12 | -0.643 | -0.292 | -11.2 | - | -1.05 | 266 | -0.364 | -0.305 | -0.718 | -1.76 | -1.85 | -0.59 | -0.533 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 266 | -11.2 | 18.9 |
P/E Ratio of other stocks in the Medical instruments industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
32.9 | - | - | $ 810 M | ||
|
Ekso Bionics Holdings
EKSO
|
-2.23 | $ 10.97 | -2.14 % | $ 26.6 M | ||
|
Luminex Corporation
LMNX
|
83.5 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-0.046 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
113 | $ 73.25 | -2.85 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
5.01 K | $ 116.64 | -3.61 % | $ 2.87 B | ||
|
The Cooper Companies
COO
|
43.5 | $ 61.98 | -1.76 % | $ 12.3 B | ||
|
Antares Pharma, Inc.
ATRS
|
12.9 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
166 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-6.23 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
27.2 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
37.5 | - | -0.02 % | $ 16.3 B | ||
|
Microbot Medical
MBOT
|
-9.13 | $ 2.08 | -1.19 % | $ 95.2 M | ||
|
Milestone Scientific
MLSS
|
-4.16 | $ 0.32 | -2.82 % | $ 26.3 M | ||
|
iRhythm Technologies
IRTC
|
-114 | $ 122.49 | -2.35 % | $ 3.92 B | ||
|
Haemonetics Corporation
HAE
|
18.3 | $ 59.16 | -1.0 % | $ 2.98 B | ||
|
electroCore
ECOR
|
-0.00398 | $ 6.26 | 1.79 % | $ 53.1 K | ||
|
Repro Med Systems
KRMD
|
-75.5 | $ 4.01 | -1.84 % | $ 185 M | ||
|
Pulse Biosciences
PLSE
|
-23.4 | $ 21.04 | -3.62 % | $ 1.42 B | ||
|
Isoray
ISR
|
-0.309 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
59.9 | $ 451.08 | -3.33 % | $ 161 B | ||
|
Glaukos Corporation
GKOS
|
-32 | $ 116.64 | -2.55 % | $ 5.65 B | ||
|
STAAR Surgical Company
STAA
|
-11.7 | $ 26.0 | -2.64 % | $ 1.29 B | ||
|
STERIS plc
STE
|
39.3 | $ 212.66 | -3.39 % | $ 21 B | ||
|
Teleflex Incorporated
TFX
|
-7.62 | $ 135.05 | -0.34 % | $ 6.03 B | ||
|
Masimo Corporation
MASI
|
-29.4 | $ 178.56 | 0.03 % | $ 9.52 B | ||
|
InfuSystem Holdings
INFU
|
8.11 K | $ 9.85 | -3.24 % | $ 203 M | ||
|
Merit Medical Systems
MMSI
|
37.8 | $ 64.8 | -2.91 % | $ 3.83 B | ||
|
Utah Medical Products
UTMD
|
77.7 | $ 66.14 | -0.71 % | $ 214 M | ||
|
West Pharmaceutical Services
WST
|
35.6 | $ 295.56 | 1.22 % | $ 21.4 B | ||
|
Envista Holdings Corporation
NVST
|
103 | $ 26.23 | -1.02 % | $ 4.41 B | ||
|
DENTSPLY SIRONA
XRAY
|
-4.22 | $ 11.47 | -2.67 % | $ 2.29 B | ||
|
Retractable Technologies
RVP
|
-1.6 | $ 0.62 | -0.46 % | $ 18.6 M | ||
|
Pro-Dex
PDEX
|
16.8 | $ 50.62 | -1.73 % | $ 166 M | ||
|
LeMaitre Vascular
LMAT
|
44 | $ 110.54 | -1.65 % | $ 2.5 B | ||
|
Predictive Oncology
POAI
|
-0.0436 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
-56.4 | $ 20.58 | -1.54 % | $ 948 M | ||
|
Stereotaxis
STXS
|
-7.9 | $ 1.79 | -4.29 % | $ 163 M | ||
|
Baxter International
BAX
|
-10.1 | $ 17.18 | -4.32 % | $ 8.81 B | ||
|
ResMed
RMD
|
45 | $ 212.53 | -2.05 % | $ 31 B | ||
|
AtriCure
ATRC
|
-136 | $ 27.5 | -3.44 % | $ 1.31 B | ||
|
Harvard Bioscience
HBIO
|
-0.368 | $ 6.27 | -2.79 % | $ 278 M | ||
|
AngioDynamics
ANGO
|
-10.4 | $ 10.63 | -3.19 % | $ 434 M | ||
|
Becton, Dickinson and Company
BDX
|
33.5 | $ 145.61 | -2.6 % | $ 41.9 B | ||
|
Nephros
NEPH
|
-14.3 | $ 3.25 | -2.11 % | $ 33.8 M | ||
|
OraSure Technologies
OSUR
|
-3.42 | $ 2.97 | -1.33 % | $ 218 M | ||
|
Repligen Corporation
RGEN
|
0.303 | $ 113.92 | -2.99 % | $ 6.35 M |